Faricimab

Faricimab demonstrated noninferior vision gains and improved anatomical outcomes among patients with diabetic macular edema and neovascular age-related macular degeneration vs. aflibercept, according to study data.

KOLOA, Hawaii — Faricimab helped improve vision in previously untreated patients with neovascular age-related macular degeneration, according to a real-world study presented at Retina 2025.

NEW YORK — In this presentation from OSN New York Retina, Ferhina S. Ali, MD, MPH, discusses how real-world experience with new anti-VEGF therapies is measuring up to what was seen in clinical trials.

CHICAGO — In this Healio Video Perspective from Retina Subspecialty Day at the AAO meeting, Jeremiah Brown, MS, MD, presents results from the phase 4 Elevatum trial investigating faricimab for diabetic macular edema.

BARCELONA, Spain — In this Healio Video Perspective from the Euretina congress, Jennifer I. Lim, MD, speaks about the impact of early fluid reduction with anti-VEGF therapy in diabetic macular edema.

Eyes with neovascular age-related macular degeneration that switched to faricimab generally had lower rates of lesion activity, longer treatment intervals and stable visual acuity.

Patients with neovascular age-related macular degeneration who have responded poorly to anti-VEGF monotherapy may require an average of nine injections of faricimab before improvement is seen.

In this Healio Video Perspective from the ASRS meeting, Arshad M. Khanani, MD, MA, FASRS, discusses the just-released 4-year efficacy and safety outcomes of faricimab in diabetic macular edema.

SEATTLE — In this Healio Video Perspective from the ARVO meeting, Roger A. Goldberg, MD, MBA, discusses an analysis examining the resolution of hard exudates in patients with diabetic macular edema treated with faricimab vs. aflibercept.

SEATTLE — In this Healio Video Perspective from the ARVO meeting, Dolly Shuo-Teh Chang, MD, of Genentech discusses the effect of intraretinal fluid volume reduction on anatomical and visual outcomes in diabetic macular edema.